These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27226342)

  • 1. Prediction error, ketamine and psychosis: An updated model.
    Corlett PR; Honey GD; Fletcher PC
    J Psychopharmacol; 2016 Nov; 30(11):1145-1155. PubMed ID: 27226342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.
    Corlett PR; Honey GD; Aitken MR; Dickinson A; Shanks DR; Absalom AR; Lee M; Pomarol-Clotet E; Murray GK; McKenna PJ; Robbins TW; Bullmore ET; Fletcher PC
    Arch Gen Psychiatry; 2006 Jun; 63(6):611-21. PubMed ID: 16754834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From prediction error to psychosis: ketamine as a pharmacological model of delusions.
    Corlett PR; Honey GD; Fletcher PC
    J Psychopharmacol; 2007 May; 21(3):238-52. PubMed ID: 17591652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-Induced Hallucinations.
    Powers AR; Gancsos MG; Finn ES; Morgan PT; Corlett PR
    Psychopathology; 2015; 48(6):376-85. PubMed ID: 26361209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine effects on memory reconsolidation favor a learning model of delusions.
    Corlett PR; Cambridge V; Gardner JM; Piggot JS; Turner DC; Everitt JC; Arana FS; Morgan HL; Milton AL; Lee JL; Aitken MR; Dickinson A; Everitt BJ; Absalom AR; Adapa R; Subramanian N; Taylor JR; Krystal JH; Fletcher PC
    PLoS One; 2013; 8(6):e65088. PubMed ID: 23776445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine: NMDA Receptors and Beyond.
    Zorumski CF; Izumi Y; Mennerick S
    J Neurosci; 2016 Nov; 36(44):11158-11164. PubMed ID: 27807158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
    Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
    Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systems model of altered consciousness: integrating natural and drug-induced psychoses.
    Vollenweider FX; Geyer MA
    Brain Res Bull; 2001 Nov; 56(5):495-507. PubMed ID: 11750795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological effects of ketamine in healthy volunteers. Phenomenological study.
    Pomarol-Clotet E; Honey GD; Murray GK; Corlett PR; Absalom AR; Lee M; McKenna PJ; Bullmore ET; Fletcher PC
    Br J Psychiatry; 2006 Aug; 189():173-9. PubMed ID: 16880489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Daumann J; Obradovic M; Kovar KA
    Neuropsychopharmacology; 2006 Feb; 31(2):431-41. PubMed ID: 16123739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic model psychoses: prediction error, learning, and inference.
    Corlett PR; Honey GD; Krystal JH; Fletcher PC
    Neuropsychopharmacology; 2011 Jan; 36(1):294-315. PubMed ID: 20861831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathological consequences of ketamine.
    Stone JM; Pilowsky LS
    Br J Psychiatry; 2006 Dec; 189():565-6. PubMed ID: 17139048
    [No Abstract]   [Full Text] [Related]  

  • 14. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
    Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
    Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
    J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.
    Dandash O; Harrison BJ; Adapa R; Gaillard R; Giorlando F; Wood SJ; Fletcher PC; Fornito A
    Neuropsychopharmacology; 2015 Feb; 40(3):622-31. PubMed ID: 25141922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.
    Xu K; Lipsky RH
    Exp Biol Med (Maywood); 2015 Feb; 240(2):145-55. PubMed ID: 25245072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Coding Account of Psychosis.
    Sterzer P; Adams RA; Fletcher P; Frith C; Lawrie SM; Muckli L; Petrovic P; Uhlhaas P; Voss M; Corlett PR
    Biol Psychiatry; 2018 Nov; 84(9):634-643. PubMed ID: 30007575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
    Lahti AC; Koffel B; LaPorte D; Tamminga CA
    Neuropsychopharmacology; 1995 Aug; 13(1):9-19. PubMed ID: 8526975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.